ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,049Medicare Part D Prescriptions Filled, Including Refills

Rank: 216 out of 2888

$192K Total Retail Price of All Prescriptions

Rank: 1936 out of 2888

454 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 454 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 14,384 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$13 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
OMEPRAZOLE 486 464 1 7
OYSTER SHELL CALCIUM W-VIT D 431 428 10 2 244
LEVOTHYROXINE SODIUM 417 390 3 1
ASPIRIN EC 410 407 4 238
MULTIVITAMINS 395 392 10 5 260
SENNA 388 388 10 6 312
SIMVASTATIN 388 371 6 2
LISINOPRIL 335 303 8 3
ALENDRONATE SODIUM 304 303 9 23
FUROSEMIDE 293 280 10 6
DOK 285 285 11 285
LOVASTATIN 271 271 12 41
AMLODIPINE BESYLATE 257 235 13 5
ENALAPRIL MALEATE 244 244 14 49
METFORMIN HCL 209 195 15 8
SERTRALINE HCL 208 206 16 27
PANTOPRAZOLE SODIUM 205 199 17 33
LOSARTAN POTASSIUM 200 190 18 18
PLAVIX 187 187 19 40
METOPROLOL TARTRATE 187 180 19 10
NAMENDA 186 186 21 34
LORATADINE 182 181 22 317
TAMSULOSIN HCL 182 177 22 29
DONEPEZIL HCL 181 181 24 26
MAPAP 177 177 25 311
RANITIDINE HCL 170 169 26 56
GLIPIZIDE 149 146 27 50
ASPIRIN 147 147 28 341
CLOPIDOGREL 145 143 29 30
GABAPENTIN 144 134 30 13
METOPROLOL SUCCINATE 136 136 31 11
HYDROCHLOROTHIAZIDE 136 125 31 15
LACTULOSE 135 135 33 111
OMEGA-3 133 133 10 34 396
CARVEDILOL 127 115 35 21
METOCLOPRAMIDE HCL 120 120 36 116
FELODIPINE ER 119 119 37 175
ATORVASTATIN CALCIUM 102 82 38 9
SINGULAIR 102 97 38 85
VITAMIN D2 98 98 40 397
METAMUCIL 96 96 10 41 365
FENOFIBRATE 95 95 42 65
FLUTICASONE PROPIONATE 92 80 43 32
FINASTERIDE 86 84 44 102
KLOR-CON 10 86 86 44 195
GLIPIZIDE ER 85 77 46 107
KLOR-CON M20 78 76 47 90
IBUPROFEN 77 61 48 87
CILOSTAZOL 75 75 49 165
JANUVIA 74 59 50 48
RISPERIDONE 71 70 51 72
LISINOPRIL-HYDROCHLOROTHIAZIDE 70 63 52 28
ACTOS 68 67 53 108
LANTUS 65 59 54 45
SEROQUEL 63 63 55 143
AZO CRANBERRY 62 62 10 56 544
VITAMIN A & D 62 61 10 56 403
ABILIFY 61 51 58 172
BISOPROLOL FUMARATE 59 59 59 227
SPIRONOLACTONE 58 52 60 70
EXELON 57 57 61 106
VYTORIN 57 56 61 155
FISH OIL 54 52 63 575
PATADAY 54 54 63 261
QUETIAPINE FUMARATE 54 54 63 66
WARFARIN SODIUM 54 51 63 22
CARBIDOPA-LEVODOPA 53 53 67 113
CITALOPRAM HBR 53 39 67 24
HYDROCODONE-ACETAMINOPHEN 51 35 S3 69 4
DICLOFENAC POTASSIUM 51 51 69 291
VENLAFAXINE HCL ER 50 44 71 120
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 3, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.